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Abstract
l-Tetrahydropalmatine (l-THP) is an active ingredients of Corydalis yanhusuo W.T. Wang, which protects against acute global
cerebral ischaemia-reperfusion injury. In this study, we show that l-THP is cardioprotective in myocardial ischaemia-
reperfusion injury and examined the mechanism. Rats were treated with l-THP (0, 10, 20, 40 mg/kg b.w.) for 20 min before
occlusion of the left anterior descending coronary artery and subjected to myocardial ischaemia-reperfusion (30 min/6 h).
Compared with vehicle-treated animals, the infarct area/risk area (IA/RA) of l-THP (20, 40 mg/kg b.w.) treated rats was
reduced, whilst l-THP (10 mg/kg b.w.) had no significant effect. Cardiac function was improved in l-THP-treated rats whilst
plasma creatine kinase activity declined. Following treatment with l-THP (20 mg/kg b.w.), subunit of phosphatidylinositol 3-
kinase p85, serine
473 phosphorylation of Akt and serine
1177 phosphorylation of endothelial NO synthase (eNOS) increased in
myocardium, whilst expression of inducible NO synthase (iNOS) decreased. However, the expression of HIF-1a and VEGF
were increased in I30 minR6h , but decreased to normal level in I30 minR24 h, while treatment with l-THP (20 mg/kg b.w.)
enhanced the levels of these two genes in I30 minR24 h. Production of NO in myocardium and plasma, activity of
myeloperoxidase (MPO) in plasma and the expression of tumour necrosis factor-a (TNF-a) in myocardium were decreased
by l-THP. TUNEL assay revealed that l-THP (20 mg/kg b.w.) reduced apoptosis in myocardium. Thus, we show that l-THP
activates the PI3K/Akt/eNOS/NO pathway and increases expression of HIF-1a and VEGF, whilst depressing iNOS-derived NO
production in myocardium. This effect may decrease the accumulation of inflammatory factors, including TNF-a and MPO,
and lessen the extent of apoptosis, therefore contributing to the cardioprotective effects of l-THP in myocardial ischaemia-
reperfusion injury.
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Introduction
Ischaemia/reperfusion (I/R) injury is an important complica-
tion of acute arterial occlusion and subsequent recanalisation; for
example, following acute myocardial infarction, coronary artery
recanalisation by thrombolytic therapy or percutaneous coronary
intervention is used therapeutically in an attempt to minimize the
infarct area. However the reoxygenation of the ischaemic heart
leads to an area of myocardial loss of function [1,2]. Many
signaling molecules have been postulated to contribute to
ischaemia-reperfusion injury including both reactive oxygen
species and nitric oxide (NO).
NO, acting as a signaling molecule, plays a major regulatory
role in several aspects of cellular function; for example, it causes
vasodilatation, inhibits platelet function and leukocyte-endothelial
interaction and modulates neurotransmission [3,4,5]. NO can also
exert a potent anti-inflammatory effect, by suppressing adhesion
molecule expression and cytokine release [6,7]. Hypoxia-inducible
factor-1 (HIF-1), is a transcription factor expressed in response to a
decrease in the partial pressure of cellular oxygen. It is a
heterodimer composed of a and b subunits. HIF-1a is stable in
physiological condition and exquisitely sensitive to the onset of
cellular hypoxic conditions, while HIF-1b is constitutive and not
sensitive to hypoxia [8,9,10]. HIF-dependent genes, such as
vascular endothelial growth factor (VEGF), are important in I/R
injury via regulating collateral vessel development [9,11].
Tetrahydroprotoberberines (THPBs) are a series of alkaloids,
isolated from a Chinese analgesic medicine, called Corydalis
yanhusuo W. T. Wang. l-Tetrahydropalmatine (l-THP), one of its
main active ingredients, has been demonstrated to have potent
analgesic effects and has been in use in Chinese clinical practice
for this purpose for many years [12,13]. Its chemical structure is
shown in Figure 1. Studies have shown that giving l-THP, 2 or
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ischaemia-reperfusion injury in rats [14,15]. Corydalis yanhusuo W.
T. Wang has also been used in China for the treatment of a variety
of cardiovascular diseases, and l-THP is once again believed to be
the main active principle. More recent studies have suggested that
another important mechanism of l-THP protection against global
cerebral ischaemia-reperfusion injury is through reducing apop-
tosis by modulating the expression of heat shock protein 70, bcl-2
and bax [16,17]. Additionally, ethanolic extracts of Corydalis
yanhusuo W. T. Wang administered orally have been reported to
protect against heart failure following induction of myocardial
infarction in rats [18].
We hypothesized that l-THP protects the myocardium from
ischaemia-reperfusion injury following acute coronary artery
occlusion. The aim of the present study was therefore to
investigate this possibility and to delineate the possible mecha-
nisms by which l-THP is cardioprotective in this context.
Methods
Experimental animals and Ethics Statement
Male Sprague-Dawley rats (250–300 g) were purchased from
the Laboratory Animal Resources of Nanjing Medical University
(NJMU). The animals were fed a laboratory diet with water and
food and kept under constant environmental conditions, with 12-
hour light/dark cycles. Animal Resources at the NJMU were in
accordance with the guidelines for the Principles of Laboratory
Animal Care and the Guide for the Care and Use of Laboratory
Animals. All aspects of animal care and all experimental protocols
were approved by the NJMU Committee on Animal Care.
Experimental model of myocardial ischaemia-reperfusion
injury
Rats were anaesthetized with sodium pentobarbital (40 mg/kg
intraperitoneally), given atropine (0.1 mg/kg subcutaneous injec-
tion) to reduce airway secretions, and artificially ventilated.
Intraoperative monitoring of adequate anaesthesia is done by toe
pinch. Myocardial ischaemia was induced by making a slipknot
(6/0 silk) around the left anterior descending coronary artery
(LAD), through a left thoracic incision. After 30 min ischaemia,
the slipknot was loosened and the myocardium was reperfused for
6h ( I 30 minR6h )o r2 4 h( I 30 minR24 h). 20 min prior to LAD
ligation, rats were treated with either vehicle (same volume of Tris-
HCl, pH 3.5) or l-THP (10, 20 or 40 mg/kg b.w.) by gavage,
which ensures that l-THP could reach effective plasma concen-
tration [15,19,20]. Sham-treated rats were given the same surgical
operation without the slipknot and ligation-unlocked.
Determination of myocardial infarct size
Myocardial infarct size was determined by Evans blue/
triphenyltetrazolium chloride (TTC) staining as described previ-
ously [21,22]. Briefly, for heart extraction, deep anaesthesia is
achieved by overdose of sodium pentobarbital (60 mg/kg intra-
peritoneally) given at 0.2 ml/100 g b.w., the hearts were removed
and perfused with saline using a Langendorff system, to wash
blood from the coronary vasculature, followed by staining with
1.5% w/v Evans blue to determine the area at risk. The heart was
then sliced horizontally into five slices, which were incubated in
1.2% TTC prepared with Tris Buffered Saline (TBS, pH 7.8) for
15 min at 37uC. Viable non-ischemic myocardium stains blue with
Evans blue; ischemic but viable myocardium stains red with TTC;
whilst necrotic myocardium does not stain with either and appears
pale white. The infarct area (white) and the area at risk (red and
white) from each section were determined using an AlphaEaseFC
image analyzer (Alpha Innotech Corporation. CA, USA). Ratios
of risk area to total left ventricle area (RA/LV) and infarct area to
risk area (IA/RA) were calculated and expressed as percentages.
Echocardiography
Rats were anaesthetized by inhalation with mild isoflurane (0.5–
1.5%, Isoflurane Vaporizer, Matrx VIP3000, USA) and anchored
to a positionable platform in a supine position. Cardiac function
was evaluated by echocardiography using GE Vivid 7 equipped
with a 14-MHz phase array linear transducer S12, allowing a 150
maximal sweep rate (General Electric Company, Connecticut,
USA). All measurements were made by one observer who was
blinded with respect to the identity of the treatments administered
and were averaged over five consecutive cardiac cycles.
Determination of creatine kinase activity
Plasma creatine kinase (CK) activity was determined spectro-
photometrically at 340 nm by a commercial kit (Nanjing
Jiancheng Bio-engineering Institute, China). In brief, CK catalyzes
the phosphorylation of ADP, in the presence of creatine
phosphate, to form ATP and creatine. The catalytic activity is
determined from the rate of NADPH formation, measured by
absorbance at 340 nm, by determining the hexokinase and
glucose-6-phosphate dehydrogenase coupled reactions.
Determination of myocardial and plasma
myeloperoxidase activity
At the end of reperfusion, the ischaemic/reperfused cardiac
tissues and serum were frozen and stored at 280uC. Myeloper-
oxidase (MPO) activity, an enzyme occurring almost exclusively in
neutrophils, was determined by a commercial assay kit (Nanjing
Jiancheng Bio-engineering Institute, China). In brief, cardiac tissue
was homogenized in 50 mmol/l potassium phosphate buffer,
pH 6, containing 0.5% hexadecyltrimethyl ammonium bromide.
The homogenates were centrifuged for 10 min at 12,5006ga t
4uC. The supernatants were collected and reacted with 0.167 g/L
o-dianisodine dihydrochloride and 0.0005% H2O2 in 50 mmol/L
phosphate buffer, and absorbance determined spectrophotomet-
rically at 460 nm.
Determination of NO Production
Total NO production in left ventricle of cardiac tissue was
determined by measuring the concentration of nitrite, a stable
metabolite of NO, with a modified Griess reaction as described
[23]. The levels of NO in plasma was determined using a NO-
specific microelectrode (World Precise Instrument, USA ).
Figure 1. The chemical structure of l-THP.
doi:10.1371/journal.pone.0038627.g001
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Total RNA was extracted from cardiac tissues using Trizol
(Invitrogen, Carlsbad, CA) and reverse transcribed into cDNA
using the Prime Script RT reagent kit (Takara Biotechnology,
China) according to the manufacturer’s instructions. mRNA levels
of target genes were quantified using SYBR Green Master Mix
(Takara Biotechnology, China) with ABI PRISM 7500 Sequence
Detector system (Applied Biosystems, CA). The primer sequences
were as follows: HIF-1a (forward, 59-ACTGATTGCATCTC-
CACCTTCT-39; reverse, 59-TCGCTTCCTCTGAGCATTCT-
39); iNOS (forward, 59-GCTACACTTCCAACGCAACA-39;
reverse, 59-ACAATCCACAACTCGCTCCA39); VEGF (forward,
59-TGCACCCACGACAGAAGGG-39; reverse, 59-
TCACCGCCTTGGCTTGTCA–CAT-39). Samples were nor-
malized against 18 s (forward, 59-GTAACCCGTTGAACCC-
CATT-39; reverse, 59-CCATCCAATCGGTAGTAGCG-39) ex-
pression to ensure equal loading.
Western blotting
At the end of reperfusion, the hearts were removed and the
ischaemic area of cardiac tissue was homogenized in lysis buffer
(final composition in mmol/l: NaCl 150; TRIS 25; Na fluoride 50;
Na orthovanadate 1.0; phenylmethylsulfonyl fluoride 1.0; aproti-
nin 1 mg/l; leupeptin 10 mg/l; pH 7.6). The homogenates were
placed on ice for 40 min, then centrifuged for 10 min at 12,5006
ga t4 uC. The supernatants, comprising cardiac lysates, were
subjected to SDS-PAGE using a 7.5% or 10% acrylamide gel,
followed by Western blotting. Proteins on the gel were transferred
to a polyvinylidene fluoride membrane for 2 h at 15 V. The
membranes were blocked for 2 h at room temperature in TBS-
Tween 20 (0.02%) containing 3% bovine serum albumin, followed
by probing with anti-p85a subunit of PI3K (rabbit polyclonal,
Santa Cruz Biotechnology Inc, USA), anti-phospho-eNOS
(Ser
1177) (rabbit polyclonal, Cell Signaling Technology Inc. MA,
USA), anti-eNOS (mouse monoclonal, Sigma, MO, USA), anti-
phospho-Akt (Ser
473) (rabbit polyclonal, Sigma, USA), anti-Akt
(rabbit polyclonal, Cell Signaling Technology Inc. MA, USA),
anti-iNOS (rabbit polyclonal, Bioworld Technology Inc. MD,
USA), anti-HIF-1a (rabbit polyclonal, Santa Cruz Biotechnology
Inc, USA) or anti-HIF-1b (rabbit monoclonal, Cell Signaling
Technology Inc. MA, USA), dilution 1:1000 in blocking buffer at
4uC overnight. After 3 washes with TBS-Tween 20 (0.02%), the
appropriate secondary antibody was added at room temperature
for 2 h. Excess antibody was removed by washing 3 times with
TBS-Tween 20 (0.02%). The membranes were covered with
Enhanced Chemiluminescence (ECL) Western blotting detection
reagents (Amersham Biosciences, NJ, USA) for 1 min, and then
exposed to Hyperfilm for up to 15 min. The films were scanned
into Microsoft Windows XP Paint software using a ScanJet 3400C
scanner (Hewlett Packard, CA, USA). The area-density product of
each band was measured using Image J 1.25 s software (National
Institutes of Health, MD, USA). p-Akt or p-eNOS immunoblots
were then stripped with stripping buffer (100 mM 2-mercaptoeth-
anol; 2% (w/v) SDS; 62.5 mM Tris-HCl; pH 6.7) at 50uC for
30 min, and re-probed for total Akt or eNOS.
Measurement of superoxide anion generation
Cardiac tissue samples were homogenized and centrifuged as
described above for western blotting. The supernatant was used
for measurement of superoxide anion production by lucigenin-
enhanced chemiluminescence. The light reaction between super-
oxide and lucigenin (5 mmol/L) was detected in a 96-well
microplate luminometer (GloMax, Promega, USA) during incu-
bation in a HEPES-modified Krebs buffer (pH 7.4). Additionally,
hearts removed from rats were immediately frozen in Tissue-Tek
OCT embedding medium (Sakura Finetek, Tokyo, Japan), then
cut into 5 mm-thick sections and placed on glass slides.
Dihydroethidium (DHE, 2 mmol/L) was applied to each tissue
section and the slides incubated in a light-protected humidified
chamber at 37uC for 15 min. The slides were then examined by
fluorescence microscopy (Olympus, Japan).
Determination of myocardial peroxynitrite (ONOO
2)
production
Cardiac tissue samples were homogenized on ice in 20 mM
HEPES buffer containing 1 mM EDTA, protease inhibitors
(Roche, Germany), and PMSF 1 mM (Sigma, USA). After
centrifugation (10 min, 800 g, 4uC) the supernatant was used for
measurement of peroxynitrite production by luminol-enhanced
chemiluminescence [24]. The light reaction between ONOO
2
and luminol(250 mmol/L) was detected in a 96-well microplate
luminometer (Biotek, USA) during incubation in a HEPES-
modified Krebs buffer (pH 7.4).
Determination of myocardial TNF-a production
Myocardial expression of TNF-a was determined using
commercially available enzyme-linked immunosorbent assay kits
(Bender, BMS622, Minneapolis, USA). Protein concentration in
the samples was measured by BCA Protein Assay (PIERCE, USA),
with bovine serum albumin used as the standard.
Myocardial apoptosis
For terminal deoxynucleotidyl-transferase mediated dUTP nick-
end labeling (TUNEL) staining, hearts were fixed in 4% v/v
paraformaldehyde, embedded in paraffin, cut into 5-mm thickness
sections and treated as indicated in the In Situ Cell Death
Detection kit, POD (Roche, Germany). Following this, sections
were co-stained with hematoxylin (Beyotime, China) to identify
cardiomyocytes.
Statistical analysis
All data are expressed as mean 6 SEM. Comparisons between
treatment groups were by Student’s t test (paired or unpaired) or
ANOVA, with or without repeated measures, as appropriate.
Differences were considered significant at P,0.05 (two-tailed).
Results
l-THP dose-dependently decreases myocardial infarct size
in rats following myocardial I/R
30 min ischaemia followed by 6 h reperfusion resulted in
myocardial injury, as expected (Figure 2). After I/R injury,
myocardial IA/RA ratio was 36.363.9% in the vehicle group but
was reduced to 20.562.2% and 18.662.2% after treated with l-
THP at either a moderate dose (20 mg/kg.) or a high dose
(40 mg/kg b.w.) respectively. No effect of l-THP on infarct size
was detected at a low dose (10 mg/kg ).
l-THP dose-dependently improves left ventricular
function in rats following myocardial I/R
Compared to the sham-operated group, 30 min ischaemia
followed by 6 h reperfusion, ejection fraction (EF) and fractional
shortening (FS) in the vehicle-treated group were significantly
decreased. Treatment with l-THP (10, 20 and 40 mg/kg b.w.),
both EF and FS following ischaemia-reperfusion were significantly
increased (Figure 3).
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30 min ischaemia followed by 6 h reperfusion resulted in
increased plasma CK activity (Figure 4a). Treatment with l-THP
(10–40 mg/kg) progressively decreased CK activity following
ischaemia-reperfusion.
l-THP decreased myocardial and plasma
myeloperoxidase activity
It is well established that myocardial I/R injury involves an
inflammatory response where neutrophils play a critical role.
30 min of ischaemia followed by 6 h reperfusion increased MPO
activity in both plasma and myocardium. l-THP (20 mg/kg b.w.)
treatment significantly attenuated the elevation in both plasma and
myocardial MPO activity, consistent with an inhibitory effect on
neutrophil function (Figure 4b–c).
l-THP dose-dependently decreases myocardial and
plasma NO biosynthesis
NO production in myocardium and plasma of rats subjected to
I/R was higher than the sham group (Figure 5a–b). Treatment
with l-THP (10–40 mg/kg b.w.) significantly decreased myocar-
dial NO generation following ischaemia-reperfusion.
l-THP increases p85, serine
1177 phosphorylation of eNOS
and serine
473 phosphorylation of Akt in myocardium
The PI3K-Akt-eNOS pathway has been reported to play a
protective role in myocardial I/R [21]. As shown in Figure 5c, l-
THP (20 mg/kg b.w.) significantly increased the expression of p85
in myocardium. Serine
1177 phosphorylation of eNOS is an
important post translational modification by which eNOS activity
is increased in response to a variety of physiological stimuli [25].
To determine whether the decrease in myocardial NO production
in response to l-THP might be due to inhibition of eNOS, through
a decrease in its serine
1177 phosphorylation, we examined this as
well as total expression of eNOS by Western blotting of
myocardial lysates. As shown in Figure 5d, l-THP (20 mg/kg
b.w.) significantly increased eNOS serine
1177 phosphorylation,
with no corresponding alteration in total eNOS expression in
myocardium. One of the most important enzymes mediating
serine
1177 phosphorylation-dependent activation of eNOS is
protein kinase Akt [26]. The active form of Akt is phosphorylated
at serine
473 and threonine
308. We therefore measured serine
473-
phosphorylated Akt as an index of Akt activation, in response to l-
THP (20 mg/kg b.w.), by Western blotting. As shown in Figure 5e,
serine
473-phosphorylated Akt in l-THP group was increased
significantly compared with vehicle group, but there was no
corresponding change in total Akt expression in the myocardium.
Figure 2. l-THP decreased myocardial infarct size in myocardial I/R (MI/R) rats. (a) RA (risk area)/LV (left ventricle area) ratio. RA/LV ratio was
not changed. (b) IA (infarct area)/RA ratio. Compared with the vehicle group (V), IA/RA ratio was significantly lower in rats that treat with l-THP(M) and
l-THP(H), *P,0.05, **P,0.01 vs. vehicle group, n=6, but l-THP(L) shows no effect. (c) Representative heart sections, compared with vehicle, infarct
area was reduced in the heart by l-THP (M) and l-THP (H).
doi:10.1371/journal.pone.0038627.g002
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in myocardium
Various studies have demonstrated that pathological concen-
trations of NO produced by iNOS may result in nitrative stress
and tissue injury, largely by generating the powerful nitrative
molecule peroxynitrite (ONOO
2) [27,28]. Accordingly, we
measured ONOO
2 levels in each group by luminol-enhenced
chemiluminescence. As shown in Figure 5f, increased ONOO
2
production was detected after cardiac I/R, which was attenuated
by treatment with l-THP (20–40 mg/kg b.w.). To investigate
whether the decrease in myocardial NO production in response to
l-THP might be explained by a decrease in iNOS expression, we
examined iNOS expression in both protein and mRNA levels. As
shown in Figure 5g, l-THP (20 mg/kg b.w.) decreased total
expression of iNOS in myocardium by western blotting. l-THP
(20 mg/kg b.w.) also reduced the iNOS mRNA level in the
myocardium after I/R (Figure 5h).
l-THP affects the expression of HIF-1 and VEGF
Compared with sham group, the expression of HIF-1a mRNA
increased in the ischaemic region of myocardium in I30 minR6h ,
but there wasn’t apparent alteration in I30 minR24 h (Figure 6a–b).
Interestingly, after treatment with l-THP, the expression of HIF-
1a mRNA increased significantly in I30 minR24 h, while it closed to
the level of sham group in I30 minR6h . The changes of VEGF
mRNA in both reperfusion at 6 h and at 24 h were similar to
those of HIF-1a (Figure 6c–d). This indicated that at temporary
ischaemia, expression of HIF-1a and VEGF were increased, but
that after a longer time of reperfusion, HIF-1a and VEGF were
reduced to basal levels. l-THP increased the expression of HIF-1a
and VEGF mRNA levels in I30 minR24 h.
l-THP decreases myocardial superoxide anion
Reactive oxygen species are believed to play a critical role in I/
R injury. Fluorescence microscopy of DHE-stained cardiac
sections, as well as lucigenin chemiluminescence of cardiac
homogenates, revealed increased superoxide anion production
after cardiac I/R, which was abolished by treatment with l-THP
(20–40 mg/kg b.w.) (Figure 7a–b).
l-THP decreases TNF-a production by myocardium
TNF-a is a multifunctional pro-inflammatory cytokine that
regulates neutrophil infiltration [29]. We found that TNF-a
concentration was increased in myocardium of rats subjected to
myocardial I/R (Figure 7c). Treatment with l-THP (20 mg/kg
b.w.) significantly reduced cardiac TNF-a concentration.
l-THP reduced myocardial apoptosis
Because apoptosis is a major event of I/R injury, we
additionally evaluated the effect of l-THP on apoptosis in this
study. As demonstrated in Figure 7d–e, the number of TUNEL-
positive cells in the ischaemic border zone was smaller in l-THP
treated animals than vehicle-treated animals, which decreasing
from 26.262.8% to 15.461.6%.
Figure 3. l-THP improves the left ventricular function of myocardial I/R rats. (a) Typical M-mode echocardiograms (b, c) I/R induced a
pronounced reduction in left ventricular ejection fraction (EF) and fractional shortening (FS), both effects being prevented by l-THP.
###P,0.001 vs.
sham group (S),*P,0.05,** P,0.01, ***P,0.001vs. vehicle group, n=6.
doi:10.1371/journal.pone.0038627.g003
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Myocardial infarction, and consequent loss of functional
myocardium, is a major cause of heart failure. Despite interven-
tional treatment or thrombolysis, prognosis remains poor in
patients with large infarct area and/or severe left ventricular
dysfunction. As well as the damage caused by ischaemia, a further
volume of functional myocardium is lost immediately after
reperfusion (within several hours), and this reperfusion damage is
a major determinant of post-myocardial infarction. Cardioprotec-
tion before reperfusion may confer some benefit in reducing
myocardial I/R injury [30], and certain drugs such as statins [31]
and angiotensin receptor blockers [32], have been shown to
decrease cardiovascular morbidity and mortality when adminis-
tered before elective cardiac surgery or percutaneous coronary
intervention.
The results of the present study indicate that the infarct size of l-
THP-treated rats was significantly reduced compared with
untreated rats whilst cardiac function was significantly improved,
following myocardial ischaemia and subsequent reperfusion.
Moreover, this effect was explained, in large part, by a decrease
in myocardial NO production. NO plays a crucial role in many
aspects of the pathophysiology of heart failure. NO has often been
described as a ‘double-edged’ sword; NO inhibits I/R injury,
represses inflammation, and prevents left ventricular (LV) remod-
eling, whereas excess NO and coexistence of reactive oxygen
species (ROS) with NO are injurious [33]. NO donors have also
been reported to increase cardiomyocyte death and to switch the
nature of cell death from apoptosis to necrosis, in a concentration-
dependent manner [34]. The detrimental effect of excessive NO is
attributable to its action on mitochondria. NO inhibits the
mitochondrial respiratory chain, resulting in inhibition of ATP
production, as well as increase in production of reactive oxygen
species and an increase in susceptibility to cell death [35,36].
During reperfusion, due to disturbance in the redox state of the
cells, excess NO can combine with superoxide anion, resulting in
formation of the reactive radical peroxynitrite (ONOO
2), which
inhibits mitochondrial respiration at multiple sites, and also causes
mitochondrial permeability transition pore (MPTP) opening
[37,38]. This in turn leads to membrane lipid peroxidation and
in the interruption of normal signalling pathways.
The PI3K/Akt/eNOS/NO pathway has been reported to play
a protective role in myocardial I/R [21]. After agonist stimulation
of PI3K, cytoslic Akt translacates to the plasma menbrance where
it is activated by serine and threonine phosphorylation. This
membrane-activated form of Akt has been shown to phosphorylate
human eNOS specifically at serine 1177, resulting in enhanced
eNOS activity and increased NO release [26,39]. Upregulation of
eNOS has been reported to protect against myocardial I/R injury
through suppression of vascular cell adhesion molecule expression
thereby preventing excessive leukocytic tissue infiltration [40].
However, activation of iNOS, induced by pro-inflammatory
cytokines, has been associated with myocardial depression [41].
Excessive generation of NO by iNOS is detrimental to cardiovas-
cular function, as exemplified in septic shock where burst
generation of iNOS-derived NO causes hypotension, cardiode-
pression and vascular hyporeactivity [42]. Supplementation with
L-arginine under conditions where iNOS is expressed during
myocardial I/R has been shown to result in a significant surge in
the production of NO and ONOO
2, which aggravate post-
ischemic myocardial apoptosis [43]. A recent study has demon-
strated that myocardial I/R stimulates polymorphonuclear leuko-
cyte accumulation, resulting in myocardial injury through an
iNOS-mediated mechanism involving generation of NO and
Figure 4. l-THP decreased the activity of creatine kinase and myeloperoxidase. (a) Plasma CK activity of myocardial I/R rats treated with
vehicle and l-THP. Plasma CK activity was significantly decreased in rats that treat with l-THP,
###P,0.001 vs. sham group, ***P,0.001 vs. vehicle
group, n=6. (b) Cardiac MPO activity of myocardial I/R rats treated with vehicle and l-THP (M). (c) Plasma MPO activity of myocardial I/R rats treated
with vehicle and l-THP (M). Compared with the vehicle group, both cardiac and plasma MPO activity was significantly decreased,
##P,0.01,
###P,0.001 vs. sham group, **P,0.01, ***P,0.001 vs. vehicle group, n=6.
doi:10.1371/journal.pone.0038627.g004
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2, and that treatment with FeTMPyP, a peroxynitrite
decomposition catalyst, reduces I/R-induced, L-arginine-en-
hanced nitrative stress and cardiomyocyte apoptosis [44]. These
studies indicate that inhibition of iNOS activity or scavenging of
peroxynitrite reduces nitrative stress and thereby attenuates tissue
injury during myocardial I/R In the present study, l-THP
treatment resulted in eNOS ser
1177 phosphorylation, via augmen-
tation of Akt ser
473 phosphorylation, during myocardial I/R.
However, this effect is outweighed by inhibition of iNOS
expression by l-THP during myocardial I/R, resulting in a net
decrease in NO production and hence cardioprotection. Growing
evidence has indicated that HIF plays a major role in myocardial
I/R injury [9]. HIF-1 is a transcription factor that is expressed
following a decrease in cellular oxygen pressure [8]. VEGF is a key
modulator of vasculogenesis and angiogenesis in physiological and
pathological conditions. VEGF is a HIF-dependent gene, which is
important in I/R because of regulating collateral vessel develop-
ment [9,11]. In this study, we found that temporary ischaemia
increased expression of HIF-1a and VEGF, and after a longer
time of reperfusion, HIF-1a and VEGF mRNA decreased to basal
level, but l-THP increased the expression of HIF-1a and VEGF
mRNA levels.
In murine macrophages, in the absence of activation, the
production of the pro-inflammatory cytokine TNF-a is repressed
both at the transcriptional and translational levels [45]. However,
during myocardial I/R, TNF-a and iNOS-derived NO are
produced in large quantities by macrophages [46]. Inhibition of
the excessive production of TNF-a and/or iNOS-derived NO can
give rise to cardioprotection in such circumstances [23,25]. Our
data supported one concept that suppression of iNOS-derived NO
production may contribute, at least partially, to the suppression of
TNF-a production during myocardial I/R [47].
Figure 5. l-THP decreased level of NO, ONOO
2 and iNOS, regulated expression of p85, eNOS and Akt. (a) Cardiac NO production
concentration of myocardial I/R rats treated with vehicle, and three doses of l-THP. Compared with the vehicle group, NO production concentration
was significantly decreased,
###P,0.001 vs. sham group, ***P,0.001 vs. vehicle group, n=6. (b) The production of NO in plasma in myocardial I/R
rats treated with vehicle, and three doses of l-THP. NO concentration was significantly decreased, which compared with the vehicle group,
##P,0.01
vs. sham group, *P,0.05 vs. vehicle group, n=6. (c) p85 of myocardial I/R rats treated with vehicle and l-THP (M). p85 was significantly increased in l-
THP (M)-treated group,
#P,0.05 vs. sham group, *P,0.05 vs. vehicle group, n=5. (d) Serine
1177 phosphorylation of eNOS of myocardial I/R rats
treated with vehicle and l-THP (M). Serine
1177 phosphorylation of eNOS was significantly increased in l-THP (M)-treated group, but total eNOS
expression was not increased,
##P,0.05 vs. sham group, **P,0.01 vs. vehicle group, n=5. (e) Serine
473 phosphorylation of Akt of myocardial I/R rats
treated with vehicle and l-THP (M). Serine
473 phosphorylation of Akt was significantly increased in l-THP (M)-treated group, but total Akt expression
was not increased,
#P,0.05 vs. sham group, *P,0.05 vs. vehicle group, n=5. (f) Cardiac ONOO
2 generation, as measured by luminol-enhanced
chemiluminescence, in each of the five groups,
#P,0.05 vs. sham group, *P,0.05, **P,0.01 vs. vehicle group, n=6. (g) iNOS expression of
myocardial I/R rats treated with vehicle and l-THP (M). iNOS expression was significantly decreased in l-THP (M)-treated group,
###P,0.001 vs. sham
group, *P,0.05 vs. vehicle group, n=5. (h) The mRNA levels of iNOS in myocardial I/R rats treated with vehicle and l-THP (M). iNOS expression was
significantly decreased in l-THP (M)-treated group,
###P,0.001 vs. sham group, *P,0.05 vs. vehicle group, n=6.
doi:10.1371/journal.pone.0038627.g005
Figure 6. l-THP affected the expression of HIF-1 and VEGF. (a) The mRNA level of HIF-1a in I30 minR6h . Compared with the sham group, HIF-1a
expression significantly increased in vehicle group,
##P,0.01 vs. sham group, *P,0.05 vs. vehicle group, n=6. (b) The mRNA level of HIF-1a in
I30 minR24 h. Compared with the vehicle group, n=6. (c) The mRNA level of VEGF in I30 minR6h . Compared with the sham group, VEGF expression
significantly increased in vehicle group,
#P,0.05 vs. sham group, *P,0.05 vs. vehicle group, n=6. (d) The mRNA level of VEGF in I30 minR24 h.
Compared with the vehicle group, VEGF expression significantly increased in l-THP (M)-treated group,
##P,0.01 vs. sham group, **P,0.01 vs. vehicle
group, n=6.
doi:10.1371/journal.pone.0038627.g006
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38627MPO is a protein present in macrophages, which can be
activated by peroxynitrite which is itself a substrate for the
enzyme. In addition, nitrite formed from peroxynitrite decompo-
sition is entrapped within the phagolysosome and can serve as an
additional substrate for MPO [48]. Many studies have indicated
that MPO is specific for leukocytes, especially polymorphonuclear
neutrophils, and MPO activity has therefore been used in many
studies as an index of neutrophil accumulation in the heart
[44,49]. In the present study, we determined the activity of MPO
in both plasma and myocardium, and found that l-THP can
reduce the activity of MPO both in plasma and in myocardium,
Figure 7. l-THP decreased cardiac oxidative stress, TNF-a production and myocardial apoptosis. (a) Representative photomicrographs of
DHE-stained cardiac sections in each of the five groups. (b) Cardiac superoxide anion generation measured by lucigenin-enhanced
chemiluminescence. Compared with the sham group, superoxide anion production significantly increased in vehicle group, while decreased in l-
THP -treated group.
#P,0.05 vs. sham group, *P,0.05 vs. vehicle group, n=6. (c) Cardiac TNF-a concentration of myocardial I/R rats treated with
vehicle and l-THP (M). Compared with the vehicle group, cardiac TNF-a concentration was significantly decreased,
#P,0.05 vs. sham group, *P,0.05
vs. vehicle group, n=6. (d) The apoptosis positive cells in myocardial of myocardial I/R rats, as determined by TUNEL assay. (e) Compared with the
vehicle group, apoptosis positive cells was significantly increased,
###P,0.001 vs. sham group, **P,0.01 vs. vehicle group, n=5.
doi:10.1371/journal.pone.0038627.g007
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38627indicative of an anti-inflammatory effect, following myocardial I/
R.
Studies have showed that l-THP can protect global cerebral
ischaemia-reperfusion injury by reducing apoptosis [16,17]. In this
study, we found that l-THP decreased apoptosis in myocardium,
indicating that l-THP has an anti-apoptotic effect during
myocardial I/R.
In conclusion, the results of the present study indicate that l-
THP is cardioprotective in the context of myocardial I/R, through
a decrease in iNOS-mediated NO biosynthesis and consequent
decreases in TNF-a synthesis and neutrophil infiltration, and
lessening the extent of apoptosis. This has important potential
therapeutic consequences in the context of myocardial I/R injury.
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